TransMedics Group, Inc.
TMDX
$121.84
-$0.27-0.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 580.13% | 241.70% | 191.22% | 116.87% | 63.98% |
| Total Depreciation and Amortization | 92.93% | 141.63% | 201.91% | 196.58% | 162.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.17% | -19.91% | -28.70% | 229.75% | 255.23% |
| Change in Net Operating Assets | -0.42% | -1.47% | -11.49% | -33.80% | -128.36% |
| Cash from Operations | 732.95% | 474.60% | 247.61% | 172.36% | 78.37% |
| Capital Expenditure | 42.28% | 14.56% | -40.04% | -2,618.10% | -1,692.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 102.96% | 102.96% | 102.96% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -198.32% | -150.44% |
| Cash from Investing | 52.71% | 33.33% | -1.69% | -1,419.21% | -650.70% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | 686.20% |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -44.44% |
| Issuance of Common Stock | 258.48% | 221.72% | 144.43% | -89.11% | -95.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | -- |
| Cash from Financing | -94.32% | -94.29% | -94.38% | -97.12% | 133.06% |
| Foreign Exchange rate Adjustments | 90.57% | -377.72% | 24.79% | -53.85% | 92.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.92% | -130.04% | -143.57% | -139.80% | -13.02% |